gene

Samsung Life Science Fund, managed by Samsung Group’s venture investment arm, has invested in US biotechnology firm Latus Bio Inc. during the ...

Samsung Group announced on Tuesday that its Life Science Fund has invested in the US-based antibody-drug conjugates (ADC) and gene therapy technol...

Samsung Group is targeting the gene therapy business through investments in US biotechnology companies as the leading South Korean conglomerate is s...

South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...

South Korea's Dong-A ST announced on Friday it has signed a joint research agreement with the University of Massachusetts (UMass) Chan Medical Schoo...

SK Pharmteco Co., a South Korean contract development and manufacturing organization (CDMO), said on Wednesday it has secured management rights of t...

South Korean genome editing developer ToolGen Inc. has teamed up with Lartbio Technology, a Seoul-based transgenic animal development company, to de...

South Korea's Hyundai Engineering & Construction (Hyundai E&C) has announced plans to create a future residential model, the All Life-care H...

South Korea's molecular diagnostics company LabGenomics Co. announced on Monday that it has signed a gene testing service supply contract with Amore...

South Korean biotech firm iNtRON Biotechnology Inc. is focusing on the Middle Eastern market with the introduction of its "LiliF Halal Real-time PCR...

ST Pharm Co., a South Korean drug raw material-producing subsidiary of Dong-A Socio Holdings, said on Friday that it has finished building an R&...

Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...

South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...

Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum ...

FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...

South Korea’s major biopharmaceutical companies are rapidly embracing the cell and gene therapy business under a contract drug-making mechanis...

South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...

SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...

Samsung Group’s 150 billion won ($124 million) Life Science Fund launched last year has chosen a leading US gene therapy development company a...

SK Pharmteco, a contract development and manufacturing organization (CDMO) for pharmaceuticals, is slated to raise 400 billion ($332.2 million) to 6...

SK Inc., the investment and holding company of South Korea’s SK Group, is seeking to make COVID-19 treatment pills developed by Pfizer Inc. an...

SK Inc., the holding and investment company of SK Group, South Korea’s third-largest conglomerate, has acquired a 70% stake in Yposkesi, a Fre...

SK Holdings is in the early stages of negotiations to acquire France’s biologic contract manufacturing organization (CMO) Yposkesi, in a move ...